Edition:
United States

Intersect Ent Inc (XENT.O)

XENT.O on Consolidated Issue listed on NASDAQ Global Market

33.34USD
15 Feb 2019
Change (% chg)

$0.89 (+2.74%)
Prev Close
$32.45
Open
$32.74
Day's High
$33.85
Day's Low
$32.30
Volume
297,374
Avg. Vol
325,692
52-wk High
$42.95
52-wk Low
$25.09

Chart for

About

Intersect ENT, Inc. is a commercial-stage drug-device company. The Company develops drugs for patients with ear, nose and throat (ENT) conditions. The Company has developed a drug releasing bioabsorbable implant technology that enables targeted and sustained release of therapeutic agents. This targeted drug delivery technology... (more)

Overall

Beta: 0.63
Market Cap(Mil.): $1,018.71
Shares Outstanding(Mil.): 30.56
Dividend: --
Yield (%): --

Financials

  XENT.O Industry Sector
P/E (TTM): -- 33.65 35.99
EPS (TTM): -0.70 -- --
ROI: -17.91 12.48 12.72
ROE: -18.00 14.73 13.73

Earnings vs. Estimates